Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012 (2012), Article ID 503128, 6 pages
http://dx.doi.org/10.1155/2012/503128
Review Article

PGD Synthase and PGD2 in Immune Resposne

1Division of Applied Medicine, School of Korean Medicine, Pusan National University, Yangsan 627-870, Republic of Korea
2Department of Veterans Affairs, Jesse Brown VA Hospital, Chicago, IL 60612, USA
3Section of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois at Chicago, M/C 719, Chicago, IL 60612, USA

Received 20 March 2012; Revised 3 May 2012; Accepted 3 May 2012

Academic Editor: Carlos Henrique Serezani

Copyright © 2012 Myungsoo Joo and Ruxana T. Sadikot. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Simmons, R. M. Botting, and T. Hla, “Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition,” Pharmacological Reviews, vol. 56, no. 3, pp. 387–437, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. B. F. McAdam, I. A. Mardini, A. Habib et al., “Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation,” Journal of Clinical Investigation, vol. 105, no. 10, pp. 1473–1482, 2000. View at Google Scholar · View at Scopus
  3. D. W. Gilroy, P. R. Colville-Nash, D. Willis, J. Chivers, M. J. Paul-Clark, and D. A. Willoughby, “Inducible cyclooxygenase may have anti-inflammatory properties,” Nature Medicine, vol. 5, no. 6, pp. 698–701, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Urade and O. Hayaishi, “Prostaglandin D2 and sleep/wake regulation,” Sleep Medicine Reviews, vol. 15, no. 6, pp. 411–418, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, “The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation,” Nature, vol. 391, no. 6662, pp. 79–82, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. D. W. Gilroy, T. Lawrence, M. Perretti, and A. G. Rossi, “Inflammatory resolution: new opportunities for drug discovery,” Nature Reviews Drug Discovery, vol. 3, no. 5, pp. 401–416, 2004. View at Google Scholar · View at Scopus
  7. C. N. Serhan, S. D. Brain, C. D. Buckley et al., “Resolution of inflammation: state of the art, definitions and terms,” The FASEB Journal, vol. 21, no. 2, pp. 325–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Urade, K. Watanabe, and O. Hayaishi, “Prostaglandin D, E, and F synthases,” Journal of Lipid Mediators and Cell Signalling, vol. 12, no. 2-3, pp. 257–273, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Urade, N. Fujimoto, M. Ujihara, and O. Hayaishi, “Biochemical and immunological characterization of rat spleen prostaglandin D synthetase,” Journal of Biological Chemistry, vol. 262, no. 8, pp. 3820–3825, 1987. View at Google Scholar · View at Scopus
  10. Y. Urade and O. Hayaishi, “Prostaglandin D synthase: structure and function,” Vitamins & Hormones, vol. 58, pp. 89–120, 2000. View at Google Scholar · View at Scopus
  11. R. J. Helliwell, L. F. Adams, and M. D. Mitchell, “Prostaglandin synthases: recent developments and a novel hypothesis,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 70, no. 2, pp. 101–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Meyer and M. Thomas, “Characterization of rat spleen prostaglandin H D-isomerase as a sigma-class GSH transferase,” Biochemical Journal, vol. 311, pp. 739–742, 1995. View at Google Scholar · View at Scopus
  13. M. Ujihara, S. Tsuchida, K. Satoh, K. Sato, and Y. Urade, “Biochemical and immunological demonstration of prostaglandin D2, E2, and F2α formation from prostaglandin H2 by various rat glutathione S-transferase isozymes,” Archives of Biochemistry and Biophysics, vol. 264, no. 2, pp. 428–437, 1988. View at Google Scholar · View at Scopus
  14. Y. Kanaoka, H. Ago, E. Inagaki et al., “Cloning and crystal structure of hematopoietic prostaglandin D synthase,” Cell, vol. 90, no. 6, pp. 1085–1095, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Mahmud, N. Ueda, H. Yamaguchi et al., “Prostaglandin D synthase in human megakaryoblastic cells,” Journal of Biological Chemistry, vol. 272, no. 45, pp. 28263–28266, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Urade, M. Ujihara, Y. Horiguchi, K. Ikai, and O. Hayaishi, “The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues,” Journal of Immunology, vol. 143, no. 9, pp. 2982–2989, 1989. View at Google Scholar · View at Scopus
  17. K. Tanaka, K. Ogawa, K. Sugamura, M. Nakamura, S. Takano, and K. Nagata, “Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets,” Journal of Immunology, vol. 164, no. 5, pp. 2277–2280, 2000. View at Google Scholar · View at Scopus
  18. A. N. Christ, L. Labzin, G. T. Bourne et al., “Development and characterization of new inhibitors of the human and mouse hematopoietic prostaglandin D2 synthases,” Journal of Medicinal Chemistry, vol. 53, no. 15, pp. 5536–5548, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Kanaoka and Y. Urade, “Hematopoietic prostaglandin D synthase,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 69, no. 2-3, pp. 163–167, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Aritake, Y. Kado, T. Inoue, M. Miyano, and Y. Urade, “Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase,” Journal of Biological Chemistry, vol. 281, no. 22, pp. 15277–15286, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Urade and N. Eguchi, “Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence,” Prostaglandins & Other Lipid Mediators, vol. 68-69, pp. 375–382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. J. E. Weber, A. J. Oakley, A. N. Christ et al., “Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D2 synthase,” European Journal of Medicinal Chemistry, vol. 45, no. 2, pp. 447–454, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B. M. Psaty and C. D. Furberg, “COX-2 inhibitors—lessons in drug safety,” The New England Journal of Medicine, vol. 352, no. 11, pp. 1133–1135, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. G. Trivedi, J. Newson, R. Rajakariar et al., “Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 13, pp. 5179–5184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Rajakariar, M. Hilliard, T. Lawrence et al., “Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyΔ1214 PGJ2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 52, pp. 20979–20984, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Jordan, H. Tumani, S. Cohrs et al., “Prostaglandin D synthase (β-trace) in healthy human sleep,” Sleep, vol. 27, no. 5, pp. 867–874, 2004. View at Google Scholar · View at Scopus
  27. A. Hoffmann, H. S. Conradt, G. Gross, M. Nimtz, F. Lottspeich, and U. Wurster, “Purification and chemical characterization of β-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase,” Journal of Neurochemistry, vol. 61, no. 2, pp. 451–456, 1993. View at Google Scholar · View at Scopus
  28. K. Watanabe, Y. Urade, M. Mäder, C. Murphy, and O. Hayaishi, “Identification of β-trace as prostaglandin D synthase,” Biochemical and Biophysical Research Communications, vol. 203, no. 2, pp. 1110–1116, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Tanaka, Y. Urade, H. Kimura, N. Eguchi, A. Nishikawa, and O. Hayaishi, “Lipocalin-type prostaglandin D synthase (β-trace) is a newly recognized type of retinoid transporter,” Journal of Biological Chemistry, vol. 272, no. 25, pp. 15789–15795, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Hayaishi and Y. Urade, “Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives,” Neuroscientist, vol. 8, no. 1, pp. 12–15, 2002. View at Google Scholar · View at Scopus
  31. S. Tokudome, M. Sano, K. Shinmura et al., “Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis,” Journal of Clinical Investigation, vol. 119, no. 6, pp. 1477–1488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Osanai and K. Okumura, “Lipocalin-type PGD synthase as a novel biomarker for coronary vasospasm,” Circulation Journal, vol. 75, no. 4, pp. 784–785, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Joo, M. Kwon, R. T. Sadikot et al., “Induction and function of lipocalin prostaglandin D synthase in host immunity,” Journal of Immunology, vol. 179, no. 4, pp. 2565–2575, 2007. View at Google Scholar · View at Scopus
  34. M. Joo, M. Kwon, Y. J. Cho et al., “Lipopolysaccharide-dependent interaction between PU.1 and cJun determines production of lipocalin-type prostaglandin D synthase and prostaglandin D2 in macrophages,” American Journal of Physiology, vol. 296, no. 5, pp. L771–L779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Tanaka, Y. Miwa, K. Mou et al., “Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice,” Biochemical and Biophysical Research Communications, vol. 378, no. 4, pp. 851–856, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Ragolia, T. Palaia, C. E. Hall, J. K. Maesaka, N. Eguchi, and Y. Urade, “Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice,” Journal of Biological Chemistry, vol. 280, no. 33, pp. 29946–29955, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Ragolia, C. E. Hall, and T. Palaia, “Lipocalin-type prostaglandin D2 synthase stimulates glucose transport via enhanced GLUT4 translocation,” Prostaglandins & Other Lipid Mediators, vol. 87, no. 1–4, pp. 34–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Saleem, Z. A. Shah, Y. Urade, and S. Doré, “Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia,” Neuroscience, vol. 160, no. 1, pp. 248–254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Ragolia, T. Palaia, C. E. Hall, J. Klein, and A. Büyük, “Diminished lipocalin-type prostaglandin D2 synthase expression in human lung tumors,” Lung Cancer, vol. 70, no. 1, pp. 103–109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Fujitani, K. Aritake, Y. Kanaoka et al., “Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo,” The FEBS Journal, vol. 277, no. 6, pp. 1410–1419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Satoh, R. Moroi, K. Aritake et al., “Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor,” Journal of Immunology, vol. 177, no. 4, pp. 2621–2629, 2006. View at Google Scholar · View at Scopus
  42. R. Hokari, C. Kurihara, N. Nagata et al., “Increased expression of lipocalin-type-prostaglandin D synthase in ulcerative colitis and exacerbating role in murine colitis,” American Journal of Physiology, vol. 300, no. 3, pp. G401–G408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Ogawa, N. Hirawa, T. Tsuchida et al., “Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats,” Nephrology Dialysis Transplantation, vol. 21, no. 4, pp. 924–934, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Nagata, K. Fujimori, I. Okazaki et al., “De novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin D synthase, β-trace, in the kidneys,” The FEBS Journal, vol. 276, no. 23, pp. 7146–7158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Uehara, H. Makino, K. Seiki, Y. Urade, and L-PGDS Clinical Research Group of Kidney, “Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study,” Nephrology Dialysis Transplantation, vol. 24, no. 2, pp. 475–482, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Donadio, “Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein,” American Journal of Physiology, vol. 299, no. 6, pp. F1407–F1423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Matsuoka, M. Hirata, H. Tanaka et al., “Prostaglandin D2 as a mediator of allergic asthma,” Science, vol. 287, no. 5460, pp. 2013–2017, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Mohri, M. Taniike, H. Taniguchi et al., “Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher,” Journal of Neuroscience, vol. 26, no. 16, pp. 4383–4393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Pettipher, T. T. Hansel, and R. Armer, “Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases,” Nature Reviews Drug Discovery, vol. 6, no. 4, pp. 313–325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. M. N. Ajuebor, A. Singh, and J. L. Wallace, “Cyclooxygenase-2-derived prostaglandin D2 is an early anti-inflammatory signal in experimental colitis,” American Journal of Physiology, vol. 279, no. 1, pp. G238–G244, 2000. View at Google Scholar · View at Scopus
  51. J. Zhao, J. Zhao, K. Legge, and S. Perlman, “Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice,” The Journal of Clinical Investigation, vol. 121, no. 12, pp. 4921-30–4930, 2011. View at Publisher · View at Google Scholar
  52. S. Narumiya, T. Ogorochi, K. Nakao, and O. Hayaishi, “Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution,” Life Sciences, vol. 31, no. 19, pp. 2093–2103, 1982. View at Google Scholar · View at Scopus
  53. T. Ogorochi, S. Narumiya, N. Mizuno, K. Yamashita, H. Miyazaki, and O. Hayaishi, “Regional distribution of prostaglandins D2, E2, and F2α and related enzymes in postmortem human brain,” Journal of Neurochemistry, vol. 43, no. 1, pp. 71–82, 1984. View at Google Scholar · View at Scopus
  54. R. A. Lewis, N. A. Soter, P. T. Diamond, K. F. Austen, J. A. Oates, and L. J. Roberts 2nd, “Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE,” Journal of Immunology, vol. 129, no. 4, pp. 1627–1631, 1982. View at Google Scholar · View at Scopus
  55. L. J. Roberts 2nd, B. J. Sweetman, R. A. Lewis, K. F. Austen, and J. A. Oates, “Increased production of prostaglandin D2 in patients with systemic mastocytosis,” The New England Journal of Medicine, vol. 303, no. 24, pp. 1400–1404, 1980. View at Google Scholar · View at Scopus
  56. Y. Hirata, H. Hayashi, S. Ito et al., “Occurrence of 9-deoxy-Δ912-13,14-dihydroprostaglandin D2 in human urine,” Journal of Biological Chemistry, vol. 263, no. 32, pp. 16619–16625, 1988. View at Google Scholar · View at Scopus
  57. D. W. Gilroy, P. R. Colville-Nash, S. McMaster, D. A. Sawatzky, D. A. Willoughby, and T. Lawrence, “Inducible cyclooxygenase-derived 15-deoxyΔ1214PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis,” The FASEB Journal, vol. 17, no. 15, pp. 2269–2271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. W. L. Song, M. Wang, E. Ricciotti et al., “Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans,” Journal of Biological Chemistry, vol. 283, no. 2, pp. 1179–1188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. V. W. Pentreath, K. Rees, O. A. Owolabi, K. A. Philip, and F. Doua, “The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 84, no. 6, pp. 795–799, 1990. View at Publisher · View at Google Scholar · View at Scopus
  60. R. A. Alafiatayo, M. R. Cookson, and V. W. Pentreath, “Production of prostaglandins D2 and E2 by mouse fibroblasts and astrocytes in culture caused by Trypanosoma brucei brucei products and endotoxin,” Parasitology Research, vol. 80, no. 3, pp. 223–229, 1994. View at Publisher · View at Google Scholar · View at Scopus
  61. R. T. Sadikot, H. Zeng, A. C. Azim et al., “Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibtion of COX-2,” European Journal of Immunology, vol. 37, no. 4, pp. 1001–1009, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Y. Park, N. Hu, X. Wang et al., “Conditional regulation of cyclooxygenase-2 in tracheobronchial epithelial cells modulates pulmonary immunity,” Clinical and Experimental Immunology, vol. 150, no. 2, pp. 245–254, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. M. A. Syed, M. Joo, Z. Abbas et al., “Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages,” Experimental Cell Research, vol. 316, no. 19, pp. 3140–3149, 2010. View at Publisher · View at Google Scholar · View at Scopus